HUP0004665A3 - Anaesthetic formulation - Google Patents
Anaesthetic formulationInfo
- Publication number
- HUP0004665A3 HUP0004665A3 HU0004665A HUP0004665A HUP0004665A3 HU P0004665 A3 HUP0004665 A3 HU P0004665A3 HU 0004665 A HU0004665 A HU 0004665A HU P0004665 A HUP0004665 A HU P0004665A HU P0004665 A3 HUP0004665 A3 HU P0004665A3
- Authority
- HU
- Hungary
- Prior art keywords
- anaesthetic formulation
- anaesthetic
- formulation
- Prior art date
Links
- 230000003444 anaesthetic effect Effects 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9724506.2A GB9724506D0 (en) | 1997-11-19 | 1997-11-19 | Levobupivacaine and its use |
| GBGB9818109.2A GB9818109D0 (en) | 1998-08-19 | 1998-08-19 | Anaesthetic Formulation |
| PCT/GB1998/003479 WO1999025349A1 (en) | 1997-11-19 | 1998-11-19 | Anaesthetic formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0004665A2 HUP0004665A2 (hu) | 2001-04-28 |
| HUP0004665A3 true HUP0004665A3 (en) | 2004-05-28 |
| HU228143B1 HU228143B1 (en) | 2012-12-28 |
Family
ID=26312628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004665A HU228143B1 (en) | 1997-11-19 | 1998-11-19 | Anaesthetic formulation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5932597A (hu) |
| EP (1) | EP1032390B1 (hu) |
| JP (1) | JP2001522888A (hu) |
| KR (1) | KR100695588B1 (hu) |
| CN (1) | CN1131033C (hu) |
| AT (1) | ATE253913T1 (hu) |
| AU (1) | AU740914B2 (hu) |
| BR (1) | BR9814883A (hu) |
| CA (1) | CA2308495C (hu) |
| DE (1) | DE69819770T2 (hu) |
| DK (1) | DK1032390T3 (hu) |
| ES (1) | ES2209217T3 (hu) |
| HK (1) | HK1026848A1 (hu) |
| HU (1) | HU228143B1 (hu) |
| IL (1) | IL135922A0 (hu) |
| NO (1) | NO328684B1 (hu) |
| PT (1) | PT1032390E (hu) |
| WO (1) | WO1999025349A1 (hu) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9824161D0 (en) * | 1998-11-04 | 1998-12-30 | Darwin Discovery Ltd | Drug formulation |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| SI1575569T1 (sl) | 2002-12-13 | 2010-12-31 | Durect Corp | Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale |
| EP2415484B1 (en) | 2004-09-17 | 2014-06-18 | Durect Corporation | Sustained local anesthetic composition containing SAIB |
| US20060270708A1 (en) * | 2005-05-25 | 2006-11-30 | Navinta Llc | Novel process for preparation of isotonic aqueous injection of ropivacaine |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| DK2117521T3 (da) | 2006-11-03 | 2012-09-03 | Durect Corp | Transdermale indgivelsessystemer omfattende bupivacain |
| CA2706931C (en) * | 2007-12-06 | 2015-05-12 | Durect Corporation | Oral pharmaceutical dosage forms |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CN105612155A (zh) * | 2012-05-10 | 2016-05-25 | 塞利克斯比奥私人有限公司 | 治疗局部疼痛的组合物和方法 |
| EP2983468A4 (en) | 2013-03-15 | 2016-09-07 | Durect Corp | COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY |
| EP3331508A4 (en) * | 2015-07-13 | 2019-06-19 | Neon Laboratories Ltd. | INJECTION OF HYPERBARE SOLUTION OF LEVOBUPIVACAINE HYDROCHLORIDE COMPRISING LEVOBUPIVACAINE CHLORHYDRATE |
| CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8802564D0 (sv) * | 1988-07-08 | 1988-07-08 | Astra Ab | New synergistic preparations and a new method of alleviation of pain |
| WO1995010277A1 (en) * | 1993-10-13 | 1995-04-20 | Chiroscience Limited | Analgesic agent and its use |
| GB9321061D0 (en) * | 1993-10-13 | 1993-12-01 | Chiroscience Ltd | Analgestic agent and its use |
-
1998
- 1998-11-19 DE DE69819770T patent/DE69819770T2/de not_active Expired - Lifetime
- 1998-11-19 JP JP2000520782A patent/JP2001522888A/ja active Pending
- 1998-11-19 WO PCT/GB1998/003479 patent/WO1999025349A1/en not_active Application Discontinuation
- 1998-11-19 HU HU0004665A patent/HU228143B1/hu unknown
- 1998-11-19 AT AT98954639T patent/ATE253913T1/de active
- 1998-11-19 DK DK98954639T patent/DK1032390T3/da active
- 1998-11-19 IL IL13592298A patent/IL135922A0/xx not_active IP Right Cessation
- 1998-11-19 EP EP98954639A patent/EP1032390B1/en not_active Expired - Lifetime
- 1998-11-19 ES ES98954639T patent/ES2209217T3/es not_active Expired - Lifetime
- 1998-11-19 PT PT98954639T patent/PT1032390E/pt unknown
- 1998-11-19 US US09/195,908 patent/US5932597A/en not_active Expired - Lifetime
- 1998-11-19 KR KR1020007005443A patent/KR100695588B1/ko not_active IP Right Cessation
- 1998-11-19 CA CA002308495A patent/CA2308495C/en not_active Expired - Lifetime
- 1998-11-19 AU AU11684/99A patent/AU740914B2/en not_active Expired
- 1998-11-19 BR BR9814883-4A patent/BR9814883A/pt not_active Application Discontinuation
- 1998-11-19 CN CN98811339A patent/CN1131033C/zh not_active Expired - Lifetime
-
2000
- 2000-05-18 NO NO20002545A patent/NO328684B1/no not_active IP Right Cessation
- 2000-09-23 HK HK00106038A patent/HK1026848A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999025349A1 (en) | 1999-05-27 |
| ATE253913T1 (de) | 2003-11-15 |
| EP1032390B1 (en) | 2003-11-12 |
| EP1032390A1 (en) | 2000-09-06 |
| CA2308495C (en) | 2009-01-06 |
| CN1131033C (zh) | 2003-12-17 |
| AU740914B2 (en) | 2001-11-15 |
| BR9814883A (pt) | 2000-10-03 |
| ES2209217T3 (es) | 2004-06-16 |
| KR100695588B1 (ko) | 2007-03-14 |
| US5932597A (en) | 1999-08-03 |
| IL135922A0 (en) | 2001-05-20 |
| DE69819770T2 (de) | 2004-09-23 |
| HU228143B1 (en) | 2012-12-28 |
| NO20002545D0 (no) | 2000-05-18 |
| PT1032390E (pt) | 2004-04-30 |
| HUP0004665A2 (hu) | 2001-04-28 |
| AU1168499A (en) | 1999-06-07 |
| KR20010032241A (ko) | 2001-04-16 |
| DE69819770D1 (de) | 2003-12-18 |
| HK1026848A1 (en) | 2000-12-29 |
| DK1032390T3 (da) | 2004-03-15 |
| CA2308495A1 (en) | 1999-05-27 |
| NO20002545L (no) | 2000-05-18 |
| JP2001522888A (ja) | 2001-11-20 |
| NO328684B1 (no) | 2010-04-26 |
| CN1279607A (zh) | 2001-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9726916D0 (en) | Nasal formulation | |
| IL135295A0 (en) | 2-methyl-thieno-benzodiazepine formulation | |
| GB9715751D0 (en) | Formulations | |
| AU7389098A (en) | Local anesthetic formulations | |
| ZA9878B (en) | New formulation for inhalation | |
| EP1030654A4 (en) | PREPARATION OF OMEPRAZOLE | |
| GB2323531B (en) | Therapeutic formulations | |
| ZA9811461B (en) | New formulation | |
| ZA9710601B (en) | Novel formulation | |
| EP0978288A4 (en) | DRUG COMPOSITION | |
| HK1026429A1 (en) | New formulation | |
| HUP0004665A3 (en) | Anaesthetic formulation | |
| GB9724544D0 (en) | Novel Formulation | |
| ZA9810773B (en) | Revitalisation formulation | |
| GB9610341D0 (en) | Formulation for inhalation | |
| GB9706957D0 (en) | Formulation | |
| ZA976592B (en) | Formulation | |
| SI1032390T1 (en) | Anaesthetic formulation | |
| GB9818109D0 (en) | Anaesthetic Formulation | |
| ZA9810587B (en) | Anaesthetic formulation. | |
| GB9404989D0 (en) | Lipomimetric formulation | |
| GB9725519D0 (en) | Nasal formulation | |
| GB9721807D0 (en) | Formulation | |
| GB9725275D0 (en) | Formulation | |
| GB9704521D0 (en) | Formulations |